betulinic acid and pyrazines

betulinic acid has been researched along with pyrazines in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hajduch, M; Kvasnica, M; Sarek, J; Tislerova, I; Urban, M1
Aggarwal, BB; Pandey, MK; Sung, B1
Li, Z; Liu, M; Liu, T; Luo, J; Qiu, WW; Tang, J; Xu, J; Yang, F1
Chu, FH; Han, YT; Lei, HM; Wang, PL; Wu, GR; Xu, B; Xu, X; Yan, WQ; Zhang, CZ; Zhao, R1
Chu, F; Cui, H; Feng, W; Guo, W; Lei, H; Li, G; Li, T; Wang, P; Wang, S; Xu, B; Yang, Y; Yuan, Y; Zhang, B; Zhang, N1

Other Studies

5 other study(ies) available for betulinic acid and pyrazines

ArticleYear
Triterpenoid pyrazines and benzopyrazines with cytotoxic activity.
    Journal of natural products, 2007, Volume: 70, Issue:4

    Topics: Antineoplastic Agents, Phytogenic; Betulinic Acid; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Leukemia, T-Cell; Molecular Structure; Pentacyclic Triterpenes; Pyrazines; Structure-Activity Relationship; Triterpenes; Tumor Cells, Cultured

2007
Betulinic acid suppresses STAT3 activation pathway through induction of protein tyrosine phosphatase SHP-1 in human multiple myeloma cells.
    International journal of cancer, 2010, Jul-15, Volume: 127, Issue:2

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Betulinic Acid; Blotting, Western; Boronic Acids; Bortezomib; Cell Proliferation; Drug Therapy, Combination; Electrophoretic Mobility Shift Assay; Enzyme Activation; Flow Cytometry; Humans; Immunoenzyme Techniques; Immunosuppressive Agents; Interleukin-6; Janus Kinase 1; Janus Kinase 2; Luciferases; Multiple Myeloma; Pentacyclic Triterpenes; Protease Inhibitors; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Pyrazines; Signal Transduction; src-Family Kinases; STAT3 Transcription Factor; Thalidomide; Triterpenes; Tumor Cells, Cultured

2010
Synthesis and biological evaluation of heterocyclic ring-fused betulinic acid derivatives as novel inhibitors of osteoclast differentiation and bone resorption.
    Journal of medicinal chemistry, 2012, Apr-12, Volume: 55, Issue:7

    Topics: Acid Phosphatase; Animals; Betulinic Acid; Bone Density Conservation Agents; Bone Resorption; Cathepsin K; Cell Differentiation; Cell Line; Cell Proliferation; Crystallography, X-Ray; Female; Isoenzymes; Isoxazoles; Mice; Mice, Inbred C57BL; Osteoclasts; Ovariectomy; Pentacyclic Triterpenes; Pyrazines; Pyrazoles; Pyrimidines; RANK Ligand; Rats; Structure-Activity Relationship; Tartrate-Resistant Acid Phosphatase; Thiazoles; Triterpenes

2012
Combination of amino acid/dipeptide with ligustrazine-betulinic acid as antitumor agents.
    European journal of medicinal chemistry, 2017, Apr-21, Volume: 130

    Topics: Amino Acids; Anisoles; Antineoplastic Agents; Apoptosis; Betulinic Acid; Calcium; Cell Line, Tumor; Dipeptides; Drug Screening Assays, Antitumor; Humans; Membrane Potential, Mitochondrial; Pentacyclic Triterpenes; Pyrazines; Structure-Activity Relationship; Triterpenes

2017
BA-12 Inhibits Angiogenesis via Glutathione Metabolism Activation.
    International journal of molecular sciences, 2019, Aug-20, Volume: 20, Issue:16

    Topics: Animals; Betulinic Acid; Caenorhabditis elegans; Chorioallantoic Membrane; Drug Discovery; Human Umbilical Vein Endothelial Cells; Humans; Metabolomics; Neovascularization, Pathologic; Pentacyclic Triterpenes; Pyrazines; Triterpenes

2019